DS Healthcare Group (DSKX) vs. Inter Parfums (IPAR) Financial Contrast

Inter Parfums (NASDAQ: IPAR) and DS Healthcare Group (OTCMKTS:DSKX) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation.


How to Become a New Pot Stock Millionaire

This table compares Inter Parfums and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Inter Parfums 7.03% 7.68% 5.58%
DS Healthcare Group N/A N/A N/A

Analyst Recommendations

This is a breakdown of current ratings for Inter Parfums and DS Healthcare Group, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inter Parfums 0 3 2 0 2.40
DS Healthcare Group 0 0 0 0 N/A

Inter Parfums presently has a consensus target price of $47.60, indicating a potential downside of 1.35%. Given Inter Parfums’ higher possible upside, equities research analysts clearly believe Inter Parfums is more favorable than DS Healthcare Group.

Earnings & Valuation

This table compares Inter Parfums and DS Healthcare Group’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inter Parfums $591.25 million 2.55 $41.59 million $1.33 36.28
DS Healthcare Group $12.95 million 0.00 -$6.93 million N/A N/A

Inter Parfums has higher revenue and earnings than DS Healthcare Group.


Inter Parfums pays an annual dividend of $0.84 per share and has a dividend yield of 1.7%. DS Healthcare Group does not pay a dividend. Inter Parfums pays out 63.2% of its earnings in the form of a dividend.

Risk and Volatility

Inter Parfums has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 9.6, indicating that its share price is 860% more volatile than the S&P 500.

Insider & Institutional Ownership

55.3% of Inter Parfums shares are owned by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are owned by institutional investors. 45.4% of Inter Parfums shares are owned by company insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


Inter Parfums beats DS Healthcare Group on 11 of the 13 factors compared between the two stocks.

About Inter Parfums

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products. The company operates in two segments, European Based Operations and United States Based Operations. It offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Lanvin, Montblanc, Paul Smith, Repetto, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Agent Provocateur, Anna Sui, bebe, Dunhill, Hollister, French Connection, and Oscar de la Renta brand names, as well as under the Intimate and Aziza names. It sells its products to department stores, perfumeries, specialty stores, domestic and international wholesalers, and distributors. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1985 and is headquartered in New York, New York.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Inter Parfums Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inter Parfums and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply